Nutriband Warrant Expiration Could Deliver $5.86 Million for Texas-Based Transdermal Developer
Found this article helpful?
Share it with your network and spread the knowledge!
Nutriband Inc. (NASDAQ: NTRB), a Texas-based company developing transdermal pharmaceutical products, has confirmed that its outstanding warrants will expire as scheduled on September 30, 2026, at 5 p.m. EDT. The company stated there will be no extension or repricing of the warrants. Warrant holders may exercise at the current strike price of $6.43 per share until expiration, after which any unexercised warrants will expire in their entirety and be removed from the NTRBW Nasdaq listing.
According to the announcement, Nutriband currently has 910,904 warrants outstanding. If all warrants are exercised at the $6.43 strike price, the company could receive approximately $5.86 million in potential proceeds. This capital infusion would be significant for Nutriband as it continues to develop its portfolio of transdermal pharmaceutical products. The company’s lead product under development is an abuse-deterrent fentanyl patch incorporating its AVERSA™ abuse-deterrent technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
The expiration of these warrants is a notable event for investors and the broader Texas business community. Nutriband, which trades on the Nasdaq under the ticker NTRB, is part of the growing life sciences sector in Texas. The potential $5.86 million in proceeds could support further research and development, clinical trials, or general corporate purposes, strengthening the company’s financial position. For readers, this news highlights the importance of monitoring warrant expirations as they can impact a company’s capital structure and liquidity.
For full details, the complete press release is available at https://nnw.fm/5DRKN. More information about Nutriband can be found on its website at www.nutriband.com. The latest news and updates relating to NTRB are available in the company’s newsroom at https://nnw.fm/NTRB.
The announcement was distributed through NetworkNewsWire, a specialized communications platform focused on financial news and content distribution. NetworkNewsWire is part of the Dynamic Brand Portfolio at IBN, which provides access to a vast network of wire solutions via InvestorWire and other services. For more information about NetworkNewsWire, visit NetworkNewsWire.